13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001398344-23-009693
Total Value
$172.8M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 23,415,584 | $79.8M | 46.20% |
| 2 | TELA BIO, INC. | TELA | 4,110,709 | $43.7M | 25.31% |
| 3 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $14.7M | 8.52% |
| 4 | BIOVENTUS | BVS | 12,096,702 | $12.9M | 7.49% |
| 5 | EYEPOINT PHARMACEUTICALS INC | EYPT | 4,190,921 | $12.3M | 7.13% |
| 6 | VENUS CONCEPT, INC. | VERO | 31,337,856 | $6.9M | 3.97% |
| 7 | MEDICINOVA INC | MNOV | 1,105,941 | $2.4M | 1.38% |